Perritt Capital Management’s ProPhase Labs PRPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PRPH
SC
QOP
XT
CD
Perritt Capital Management's PRPH Position: Q2 2025 in Review
Perritt Capital Management sold out of ProPhase Labs (PRPH) in Q2 2025, closing a stake of 15,000 shares — an estimated $60.6K sold.
Perritt Capital Management first reported a position in PRPH in Q1 2021 and held it in 17 quarters. The position peaked at $1.81M in Q2 2022. 33 funds tracked by Wall St. Rank hold PRPH as of Q2 2025.
- Perritt Capital Management reported no remaining ProPhase Labs position as of Q2 2025 after selling out during the quarter.
- Perritt Capital Management sold 15,000 ProPhase Labs shares in Q2 2025, an estimated $60.6K.
- Perritt Capital Management first reported a position in ProPhase Labs in Q1 2021 and held it in 17 quarters.
- Perritt Capital Management's ProPhase Labs position peaked at $1.81M in Q2 2022.
- 33 funds tracked by Wall St. Rank held ProPhase Labs as of Q2 2025.
Based on Perritt Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.